<DOC>
	<DOCNO>NCT03087175</DOCNO>
	<brief_summary>NSTE-ACS represent frequent indication coronary angiography percutaneous coronary intervention ( PCI ) worldwide . PCI permit reestablish coronary flow effectiveness PCI within thrombus contain lesion limit risk occurrence distal embolization no-reflow phenomenon . Distal embolization lead coronary microcirculation lesion . This complication relate poor prognosis . MGuard stent stainless-steel close cell stent cover ultra-thin polymer mesh sleeve , allow prevent distal embolization percutaneous coronary intervention ST-segment-elevation myocardial infarction . Index microcirculatory resistance ( IMR ) validate method ass coronary microcirculation . Accordingly , purpose study demonstrate MGuard micronet mesh-covered stent prevent distal embolization microvascular reperfusion impairment primary PCI , compare bare metal stent ( BMS ) drug elute stent ( DES ) patient NSTE-ACS , assessed Index microcirculatory resistance .</brief_summary>
	<brief_title>MGuard Stent Microcirculation</brief_title>
	<detailed_description>GUARDIANCORY study multicentre , prospective , randomize , non inferiority , open-label trial plan inclusion 52 patient NSTE ACS prescribe PCI . Patients randomize benefit either DES /BMS implantation ( n=26 ) MGuard stent ( n=26 ) culprit lesion . Assessment coronary microcirculation do IMR immediately PCI use pressure-temperature sensor-tipped coronary wire , thermodilution-derived .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Terephthalic acid</mesh_term>
	<criteria>Age &gt; 18 year Patients affiliate social security Patients NSTEMI ( 1 ) Thrombus contain coronary lesion angiography ( TIMI thrombus grade â‰¥ 3 ) Eligible patient revascularization angioplasty Patients consent participate study . Age &lt; 18 year Prior myocardial infarction Prior CABG Inability comply protocol Major patient protect law ( article L11218 ) , Person deprive liberty ( article L11218 ) , Pregnant woman Breastfeeding woman Patient terminal illness , Terminal Renal failure Allergy iodine Adenosine 's contraindication : Asthmatic patient , Second thirddegree AV block without pacemaker sick sinus syndrome . Systolic blood pressure less 90mmHg . Recent use dipyridamole dipyridamolecontaining medication , Methyl xanthenes aminophylline caffeine theobromine block effect adenosine hold least 12 hour prior test . Known hypersensitivity adenosine . Unstable acute myocardial infarction acute coronary syndrome .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>